Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 3 1

Status

Active not recruiting 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 1Classical hematology 1

Conditions

Carcinoma, Non-Small-Cell Lung 927Neoplasms 609Breast Neoplasms 606Colorectal Neoplasms 457Neoplasm Metastasis 395Ovarian Neoplasms 327Prostatic Neoplasms 314Melanoma 311Lung Neoplasms 295Multiple Myeloma 290Recurrence 278Squamous Cell Carcinoma of Head and Neck 246Stomach Neoplasms 229Pancreatic Neoplasms 227Leukemia, Myeloid, Acute 221Triple Negative Breast Neoplasms 190Endometrial Neoplasms 190Carcinoma, Renal Cell 181Lymphoma, Non-Hodgkin 179Carcinoma, Hepatocellular 179Small Cell Lung Carcinoma 165Leukemia, Lymphocytic, Chronic, B-Cell 156Advanced Solid Tumors 155Lymphoma, Follicular 149Urinary Bladder Neoplasms 139Lymphoma, Large B-Cell, Diffuse 138Lymphoma 137Advanced Solid Tumor 137Uterine Cervical Neoplasms 134Head and Neck Neoplasms 134

Interventions

emactuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
INDUSTRY × Synovitis × 1 year × Clear all
NCT06752850 2026-04-30

A Study to Investigate the Course of Synovial Hypertrophy in Patients With Haemophilia A on Efanesoctocog Alfa Prophylaxis

Swedish Orphan Biovitrum

Phase 4 Active not recruiting
37 enrolled
Classical hematologyLymphoid

Hemophilia A, Lymphoma, Follicular, Synovitis

NCT05417789 2026-02-02

TANGENT

SynOx Therapeutics Limited

Phase 3 Active not recruiting
128 enrolled

Synovitis, Synovitis, Pigmented Villonodular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡